Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 3, 2026Feb 5 2:05 AMJonathan SheenaDirector, Other
Sale
435$230.77$100.4K263,161(D)

View →

Feb 3, 2026Feb 5 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
1,334$230.77$307.8K223,813(D)

View →

Feb 3, 2026Feb 3 9:32 PMMICHAEL BROPHY
Proposed Sale
5,671$231.10$1.3M

View →

Feb 2, 2026Feb 2 9:58 PMSTEVEN L CHAPMAN
Proposed Sale
85,299$230.72$19.7M

View →

Feb 2, 2026Feb 2 9:12 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$231.44$694.3K

View →

Jan 28, 2026Jan 30 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
3,648$237.66$867.0K213,180(D)

View →

Jan 27, 2026Jan 30 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
2,322$240.53$558.5K216,828(D)

View →

Jan 29, 2026Jan 30 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
1,867$230.40$430.2K59,059(D)

View →

Jan 28, 2026Jan 30 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
2,413$237.56$573.2K60,926(D)

View →

Jan 27, 2026Jan 30 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
784$240.53$188.6K63,339(D)

View →

Jan 28, 2026Jan 30 1:35 AMJonathan SheenaDirector, Other
Sale
191$237.66$45.4K263,596(D)

View →

Jan 27, 2026Jan 30 1:35 AMJonathan SheenaDirector, Other
Sale
291$240.53$70.0K263,787(D)

View →

Jan 28, 2026Jan 30 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
1,000$237.66$237.7K225,147(D)

View →

Jan 27, 2026Jan 30 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
886$240.53$213.1K226,147(D)

View →

Jan 28, 2026Jan 30 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,200$237.66$285.2K142,486(D)

View →

Jan 27, 2026Jan 30 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,013$240.53$243.7K143,686(D)

View →

Jan 28, 2026Jan 30 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
928$237.66$220.6K175,540(D)

View →

Jan 27, 2026Jan 30 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
784$240.53$188.6K176,468(D)

View →

Jan 29, 2026Jan 29 9:10 PMMICHAEL BROPHY
Proposed Sale
1,867$235.93$440.5K

View →

Jan 28, 2026Jan 28 9:19 PMMICHAEL BROPHY
Proposed Sale
1,176$240.34$282.6K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →